Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies. They are working on a pipeline of novel product candidates that target critical biological pathways involved in cancer. Arcus aims to develop differentiated combination therapies that can bring meaningful benefits to patients with cancer. Their approach involves both small molecule and antibody discovery and development.
The Hayward headquarters serves as the central hub for Arcus Biosciences' research and development, corporate operations, and strategic decision-making. It houses state-of-the-art laboratories and office spaces.
Modern, purpose-built facility with advanced research laboratories equipped for drug discovery and development, alongside collaborative office environments designed to foster innovation.
Arcus fosters a science-driven, innovative, and collaborative work culture. Employees are passionate about advancing cancer treatments, working in a dynamic and fast-paced environment that encourages teamwork and scientific excellence.
The headquarters is pivotal to Arcus's mission, enabling the discovery, development, and advancement of its diverse pipeline of immunotherapies. Its location provides access to a rich talent pool and a vibrant biotech ecosystem.
Arcus Biosciences supports its research and development efforts globally, with a primary focus on drug discovery in its California headquarters and clinical trial operations spanning North America, Europe, and the Asia-Pacific region. This international reach allows Arcus to conduct diverse clinical studies and engage with medical communities worldwide to advance its cancer therapies.
3928 Point Eden Way
Hayward
CA
USA
Address: Level 38, 71 Eagle Street, Brisbane QLD 4000, Australia
To manage and expand clinical development programs within Australia and the broader APAC region, engaging with local investigators and healthcare systems.
Address: 70 Sir John Rogerson's Quay, Dublin 2, Ireland
To facilitate and oversee clinical development activities across Europe, ensuring alignment with European regulatory standards and supporting engagement with the European medical community.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Arcus Biosciences' leadership includes:
Arcus Biosciences has been backed by several prominent investors over the years, including:
Arcus Biosciences has strengthened its executive team with key appointments in business and development roles over the past year. No major C-suite departures were publicly announced during this period.
Discover the tools Arcus Biosciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Arcus Biosciences primarily utilizes the email format combining the first initial and last name. This is a common convention in many corporations, especially within the biotech sector.
flast@arcusbio.com
Format
jdoe@arcusbio.com
Example
90%
Success rate
GlobeNewswire • May 23, 2024
Arcus Biosciences reported promising interim data from the EDGE-Lung Phase 2 study, showing clinical activity for domvanalimab plus zimberelimab in patients with EGFR-mutated, locally advanced or metastatic non-small cell lung cancer. The data was presented at the 2024 ASCO Annual Meeting....more
GlobeNewswire • May 7, 2024
Arcus Biosciences announced the appointment of Dimitry S.A. Nuyten, M.D., Ph.D., as its new Chief Development Officer. Dr. Nuyten brings extensive experience in oncology drug development to Arcus....more
GlobeNewswire • May 7, 2024
Arcus Biosciences provided its first-quarter 2024 financial results, highlighting progress across its clinical programs and collaborations, including updates on its anti-TIGIT, anti-PD-1, and adenosine receptor antagonist programs....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Arcus Biosciences, are just a search away.